0000950170-24-015944.txt : 20240215
0000950170-24-015944.hdr.sgml : 20240215
20240215163343
ACCESSION NUMBER: 0000950170-24-015944
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240101
FILED AS OF DATE: 20240215
DATE AS OF CHANGE: 20240215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TZIANABOS ARTHUR
CENTRAL INDEX KEY: 0001586226
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38433
FILM NUMBER: 24644320
MAIL ADDRESS:
STREET 1: C/O HOMOLOGY MEDICINES, INC.
STREET 2: ONE PATRIOTS PARK
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Homology Medicines, Inc.
CENTRAL INDEX KEY: 0001661998
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 473468154
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE PATRIOTS PARK
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: 781-301-7277
MAIL ADDRESS:
STREET 1: ONE PATRIOTS PARK
CITY: BEDFORD
STATE: MA
ZIP: 01730
4
1
ownership.xml
4
X0508
4
2024-01-01
0001661998
Homology Medicines, Inc.
FIXX
0001586226
TZIANABOS ARTHUR
C/O HOMOLOGY MEDICINES, INC.
ONE PATRIOTS PARK
BEDFORD
MA
01730
true
false
false
false
true
Common Stock
2024-01-01
4
M
false
14280
A
122675
D
Common Stock
2024-01-01
4
M
false
19140
A
141815
D
Common Stock
2024-01-09
4
S
false
13037
0.5711
D
128778
D
Restricted Stock Units
2024-01-01
4
M
false
14280
0.00
D
Common Stock
14280
0
D
Restricted Stock Units
2024-01-01
4
M
false
19140
0.00
D
Common Stock
19140
19720
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of RSUs.
The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $0.5710 to $0.5712. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3.
The RSUs are fully vested and do not have an expiration date.
The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date.
/s/ Paul Alloway, Attorney-in-Fact for Arthur O. Tzianabos
2024-02-15